Progesterone receptor gene polymorphism and risk f... [Br J Cancer. 1998]

Cited by 5 PubMed Central articles

The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome.
Karadeniz M, Erdogan M, Berdeli A, Tamsel S, Saygili F, Yilmaz C. Cardiovasc Diabetol. 2007 Oct 5; 6:29. Epub 2007 Oct 5.

[Cardiovasc Diabetol. 2007]
The progesterone receptor Val660-->Leu polymorphism and breast cancer risk.
De Vivo I, Hankinson SE, Colditz GA, Hunter DJ. Breast Cancer Res. 2004; 6(6):R636-9. Epub 2004 Sep 22.

[Breast Cancer Res. 2004]
ReviewEstrogen, progesterone and epithelial ovarian cancer.
Ho SM. Reprod Biol Endocrinol. 2003 Oct 7; 1:73. Epub 2003 Oct 7.

[Reprod Biol Endocrinol. 2003]
» See all...

Progesterone (Prometrium®)
Progesterone is used as a part of hormone replacement therapy in women who have passed menopause (the change of life) and have not had a hysterectomy (surgery to remove the uterus). Hormone replacement therapy usually in...
Source: AHFS Consumer Medication Information

References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Your browsing activity is empty.

Activity recording is turned off.